Net Cash Provided by (Used in) Operating Activities |
-504K |
USD |
-1828% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
52.6K |
USD |
+202% |
Q2 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
75M |
shares |
0% |
Q2 2024 |
Q1 2025 |
Common Stock, Shares, Issued |
25M |
shares |
+326% |
Q2 2024 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
142K |
USD |
|
Q2 2024 |
Q1 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
31.7K |
USD |
|
Q4 2024 |
Q3 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Gross |
31.7K |
USD |
|
Q4 2024 |
Q3 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
151K |
USD |
|
Q4 2024 |
Q3 2024 |
Deferred Federal Income Tax Expense (Benefit) |
0 |
USD |
|
Q2 2024 |
Q1 2025 |
Additional Paid in Capital |
1.01M |
USD |
+1622% |
Q2 2024 |
Q1 2025 |
Current State and Local Tax Expense (Benefit) |
0 |
USD |
|
Q2 2024 |
Q1 2025 |
Current Federal Tax Expense (Benefit) |
9.8K |
USD |
|
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2024 |
Q3 2024 |
Deferred State and Local Income Tax Expense (Benefit) |
0 |
USD |
|
Q2 2024 |
Q1 2025 |